Mirum Pharmaceuticals Grants Stock Options, RSUs to New Employees and Chief Medical Officer

• Mirum Pharmaceuticals granted Chief Medical Officer Rob Myers 40,000 non-qualified stock options and 25,000 restricted stock units on October 9, 2026.
• Another 18 new employees received 18,663 non-qualified stock options and 24,687 restricted stock units under the 2020 Inducement Plan.
• Stock options vest over four years: 25% on the first vesting anniversary, with the remainder monthly over 36 months.
• Restricted stock units vest over three years, with 33% vesting on each anniversary of the applicable initial vesting date.
• All awards require continued service through the applicable vesting dates; Myers' grants also fall under the 2020 Inducement Plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610151601BIZWIRE_USPR_____20261015_BW866959) on October 15, 2026, and is solely responsible for the information contained therein.